BioCentury
ARTICLE | Company News

Valeant Pharmaceuticals, Atlantis S.A. de C.V. deal

April 30, 2012 7:00 AM UTC

Valeant will acquire assets from branded generic company Atlantis, including gastrointestinal, analgesics and anti-inflammatory products for about $71 million. According to Valeant, the acquired asset...